Severin Schwan and Thomas Schinecker (Roche)
July 21, 2022 05:47 AM EDTUpdated 07:28 AM
People
Pharma

Af­ter 14 years as Roche’s CEO, Sev­erin Schwan is pass­ing the ba­ton

Amber Tong

Roche CEO Sev­erin Schwan will be mov­ing to the board chair­man role in a few months, mak­ing room for Thomas Schi­neck­er — the cur­rent chief of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The Biden ad­min­is­tra­tion wants Medicare and Med­ic­aid to cov­er GLP-1s. Will the Trump White House al­low it?

Up­dat­ed: Am­gen obe­si­ty shot shows 20% weight loss, but dos­ing ques­tions hang over read­out

Sarep­ta li­cens­es Ar­row­head­'s RNA-based rare dis­ease pipeline, promis­ing big biobucks

Ax­some moves to­ward NDA fil­ing for nar­colep­sy drug fol­low­ing pos­i­tive Phase 3 da­ta

Soleno’s rare pe­di­atric dis­ease drug faces PDU­FA de­lay by three months

Up­dat­ed: Roche buys out CAR-T part­ner Po­sei­da for $1B up­front

A service from the Financial Times